• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

少数族裔在罕见和非典型糖尿病网络(RADIANT)中的登记情况。

Enrollment of underrepresented racial and ethnic groups in the Rare and Atypical Diabetes Network (RADIANT).

作者信息

Tosur Mustafa, Gandolfo Laura, Balasubramanyam Ashok, Naylor Rochelle N, Pollin Toni I, Rasouli Neda, Cromer Sara J, Buse John B, Redondo Maria J

机构信息

Department of Pediatrics, The Division of Diabetes and Endocrinology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.

Children's Nutrition Research Center, USDA/ARS, Houston, TX, USA.

出版信息

J Clin Transl Sci. 2023 Jan 23;7(1):e47. doi: 10.1017/cts.2022.529. eCollection 2023.

DOI:10.1017/cts.2022.529
PMID:36845305
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9947614/
Abstract

INTRODUCTION

Diabetes mellitus in underrepresented racial and ethnic groups (URG) is rapidly increasing in incidence and has worse outcomes than diabetes in non-Hispanic White individuals. Rare and Atypical Diabetes Network (RADIANT) established recruitment targets based on the racial and ethnic distribution of the USA to enroll a diverse study population. We examined participation of URG across RADIANT study stages and described strategies to enhance recruitment and retention of URG.

MATERIALS AND METHODS

RADIANT is a multicenter NIH-funded study of people with uncharacterized forms of atypical diabetes. RADIANT participants consent online and progress through three sequential study stages, as eligible.

RESULTS

We enrolled 601 participants with mean age 44 ± 16.8 years, 64.4% female. At Stage 1, 80.6% were White, 7.2% African American (AA), 12.2% other/more than one race, and 8.4% Hispanic. Enrollment of URG was significantly below preset targets across most stages. Referral sources differed by race ( < 0.001) but not ethnicity ( = 0.15). Most AA participants were referred by RADIANT investigators (58.5% vs. 24.5% in Whites), whereas flyers, news, social media, and family or friends were more frequent referral sources for White individuals (26.4% vs. 12.2% in AA). Ongoing initiatives to increase enrollment of URG in RADIANT include engaging with clinics/hospitals serving URG, screening electronic medical records, and providing culturally competent study coordination and targeted advertisement.

CONCLUSIONS

There is low participation of URG in RADIANT, potentially limiting the generalizability of its discoveries. Investigations into barriers and facilitators for recruitment and retention of URG in RADIANT, with implications for other studies, are ongoing.

摘要

引言

在未得到充分代表的种族和族裔群体(URG)中,糖尿病的发病率正在迅速上升,且其预后比非西班牙裔白人的糖尿病更差。罕见和非典型糖尿病网络(RADIANT)根据美国的种族和族裔分布确定了招募目标,以纳入多样化的研究人群。我们研究了URG在RADIANT研究各阶段的参与情况,并描述了提高URG招募和保留率的策略。

材料与方法

RADIANT是一项由美国国立卫生研究院资助的多中心研究,研究对象为患有未明确类型的非典型糖尿病患者。RADIANT参与者通过在线方式同意参与研究,并根据 eligibility 依次进入三个连续的研究阶段。

结果

我们招募了601名参与者,平均年龄为44±16.8岁,女性占64.4%。在第一阶段,80.6%为白人,7.2%为非裔美国人(AA),12.2%为其他/多种族,8.4%为西班牙裔。在大多数阶段,URG的招募人数显著低于预设目标。推荐来源因种族而异(<0.001),但不因族裔而异(=0.15)。大多数AA参与者是由RADIANT研究人员推荐的(58.5%,而白人中这一比例为24.5%),而传单、新闻、社交媒体以及家人或朋友是白人更常见的推荐来源(26.4%,而AA中这一比例为12.2%)。RADIANT正在开展的增加URG招募人数的举措包括与服务URG的诊所/医院合作、筛查电子病历,以及提供具有文化胜任力的研究协调和针对性广告。

结论

URG在RADIANT中的参与度较低,这可能会限制其研究结果的普遍性。目前正在对RADIANT中URG招募和保留的障碍及促进因素进行调查,这对其他研究也有启示意义

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f01/9947614/64c0772935a2/S2059866122005295_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f01/9947614/64c0772935a2/S2059866122005295_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f01/9947614/64c0772935a2/S2059866122005295_fig1.jpg

相似文献

1
Enrollment of underrepresented racial and ethnic groups in the Rare and Atypical Diabetes Network (RADIANT).少数族裔在罕见和非典型糖尿病网络(RADIANT)中的登记情况。
J Clin Transl Sci. 2023 Jan 23;7(1):e47. doi: 10.1017/cts.2022.529. eCollection 2023.
2
Referral Sources Across Racial and Ethnic Groups at Alzheimer's Disease Research Centers.阿尔茨海默病研究中心的不同种族和族裔群体的转诊来源。
J Alzheimers Dis. 2024;101(4):1167-1176. doi: 10.3233/JAD-240485.
3
Toward representative genomic research: the children's rare disease cohorts experience.迈向具有代表性的基因组研究:儿童罕见病队列研究经验
Ther Adv Rare Dis. 2023 Aug 22;4:26330040231181406. doi: 10.1177/26330040231181406. eCollection 2023 Jan-Dec.
4
Representation of Race and Ethnicity in Randomized Clinical Trials of Diabetic Macular Edema and Retinal Vein Occlusion Compared to 2010 US Census Data.糖尿病性黄斑水肿和视网膜静脉阻塞的随机临床试验中种族和民族的代表性与 2010 年美国人口普查数据相比。
JAMA Ophthalmol. 2022 Nov 1;140(11):1096-1102. doi: 10.1001/jamaophthalmol.2022.3929.
5
Accelerating diversity in Alzheimer's disease research by partnering with a community advisory board.通过与社区咨询委员会合作加速阿尔茨海默病研究的多样性。
Alzheimers Dement (N Y). 2023 May 28;9(2):e12400. doi: 10.1002/trc2.12400. eCollection 2023 Apr-Jun.
6
Quantification of race/ethnicity representation in Alzheimer's disease neuroimaging research in the USA: a systematic review.美国阿尔茨海默病神经影像学研究中种族/族裔代表性的量化:一项系统综述。
Commun Med (Lond). 2023 Jul 25;3(1):101. doi: 10.1038/s43856-023-00333-6.
7
Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial.成年人参与临床前阿尔茨海默病试验的种族和民族差异。
JAMA Netw Open. 2021 Jul 1;4(7):e2114364. doi: 10.1001/jamanetworkopen.2021.14364.
8
Investigator and participant expectations for returning non-genetic results: insights from the Rare and Atypical Diabetes Network (RADIANT) study.研究者与参与者对返回非基因检测结果的期望:来自罕见与非典型糖尿病网络(RADIANT)研究的见解
J Clin Transl Sci. 2023 Nov 22;7(1):e260. doi: 10.1017/cts.2023.684. eCollection 2023.
9
Understanding Barriers and Facilitators to Signing Up for a Mobile-Responsive Registry to Recruit Healthy Volunteers and Members of Underrepresented Communities for Alzheimer's Disease Prevention Studies.了解健康志愿者和代表性不足社区成员报名参加移动响应注册以参与阿尔茨海默病预防研究的障碍和促进因素。
J Prev Alzheimers Dis. 2023;10(4):865-874. doi: 10.14283/jpad.2023.67.
10
Is Our Science Representative? A Systematic Review of Racial and Ethnic Diversity in Orthopaedic Clinical Trials from 2000 to 2020.我们的科学具有代表性吗?一项针对 2000 年至 2020 年骨科临床试验中种族和民族多样性的系统评价。
Clin Orthop Relat Res. 2022 May 1;480(5):848-858. doi: 10.1097/CORR.0000000000002050. Epub 2021 Dec 2.

引用本文的文献

1
A Research Roadmap to Address the Heterogeneity of Diabetes and Advance Precision Medicine.应对糖尿病异质性并推进精准医学的研究路线图。
J Clin Endocrinol Metab. 2025 Feb 18;110(3):601-610. doi: 10.1210/clinem/dgae844.
2
Identification of atypical pediatric diabetes mellitus cases using electronic medical records.利用电子病历识别非典型小儿糖尿病病例。
BMJ Open Diabetes Res Care. 2024 Nov 7;12(6):e004471. doi: 10.1136/bmjdrc-2024-004471.
3
Strategies for Equitable Recruitment to Engage Underrepresented Youth and Their Families into Clinical Research: Findings from the BEAD-T1D Pilot Study.

本文引用的文献

1
Insight on Diagnosis and Treatment From Over a Decade of Research Through the University of Chicago Monogenic Diabetes Registry.通过芝加哥大学单基因糖尿病登记处进行的十多年研究对诊断和治疗的见解。
Front Clin Diabetes Healthc. 2021 Nov;2. doi: 10.3389/fcdhc.2021.735548. Epub 2021 Nov 5.
2
Model for Integration of Monogenic Diabetes Diagnosis Into Routine Care: The Personalized Diabetes Medicine Program.单基因糖尿病诊断纳入常规护理的模式:个性化糖尿病医学计划。
Diabetes Care. 2022 Aug 1;45(8):1799-1806. doi: 10.2337/dc21-1975.
3
Cardiorenal Complications in Young-Onset Type 2 Diabetes Compared Between White Americans and African Americans.
公平招募代表性不足的青少年及其家庭参与临床研究的策略:BEAD-T1D试点研究的结果
Horm Res Paediatr. 2024 Oct 4:1-9. doi: 10.1159/000541774.
4
Recruiting historically under-represented individuals into Project ECHO Diabetes: using barrier analysis to understand disparities in clinical research in the USA.招募历史上代表性不足的个体参与 ECHO 糖尿病项目:利用障碍分析了解美国临床研究中的差异。
BMJ Open. 2023 Aug 30;13(8):e072546. doi: 10.1136/bmjopen-2023-072546.
年轻起病 2 型糖尿病患者中白种人与非裔美国人的心脏肾脏并发症比较。
Diabetes Care. 2022 Aug 1;45(8):1873-1881. doi: 10.2337/dc21-2349.
4
Age at Diagnosis of Diabetes by Race and Ethnicity in the United States From 2011 to 2018.2011 年至 2018 年美国按种族和族裔划分的糖尿病发病年龄。
JAMA Intern Med. 2021 Nov 1;181(11):1537-1539. doi: 10.1001/jamainternmed.2021.4945.
5
Trends in Prevalence of Type 1 and Type 2 Diabetes in Children and Adolescents in the US, 2001-2017.美国儿童和青少年 1 型和 2 型糖尿病患病率趋势,2001-2017 年。
JAMA. 2021 Aug 24;326(8):717-727. doi: 10.1001/jama.2021.11165.
6
Type 2 diabetes in prepubertal children.儿童期发病的 2 型糖尿病。
Pediatr Diabetes. 2021 Nov;22(7):946-950. doi: 10.1111/pedi.13254. Epub 2021 Sep 2.
7
Long-Term Complications in Youth-Onset Type 2 Diabetes.青少年 2 型糖尿病的长期并发症。
N Engl J Med. 2021 Jul 29;385(5):416-426. doi: 10.1056/NEJMoa2100165.
8
Race/ethnicity and challenges for optimal insulin therapy.种族/民族与胰岛素治疗的挑战。
Diabetes Res Clin Pract. 2021 May;175:108823. doi: 10.1016/j.diabres.2021.108823. Epub 2021 Apr 20.
9
Association of Diabetes Subgroups With Race/Ethnicity, Risk Factor Burden and Complications: The MASALA and MESA Studies.糖尿病亚组与种族/族裔、危险因素负担及并发症的关联:MASALA和MESA研究
J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2106-e2115. doi: 10.1210/clinem/dgaa962.
10
Diabetes Complications in Racial and Ethnic Minority Populations in the USA.美国少数民族群体中的糖尿病并发症。
Curr Diab Rep. 2021 Jan 9;21(1):2. doi: 10.1007/s11892-020-01369-x.